Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (41-50 of 230) with videos related to

Pageof 23
Sort By:
Annals of Surgical Oncology|March 23, 2018
Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy RadiotherapyShirin Muhsen, Tracy-Ann Moo, Sujata Patil, et al.
Annals of Surgical Oncology|February 4, 2014
Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodesTracy-Ann Moo, Robert McMillan, Michele Lee, et al.
Annals of Surgical Oncology|November 20, 2012
Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?Daniel X Choi, Anne A Eaton, Cristina Olcese, et al.
Annals of Surgical Oncology|August 27, 2013
Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodesTracy Ann Moo, Robert McMillan, Michele Lee, et al.
Leukemia & Lymphoma|May 25, 2023
Ki67 proliferation index in follicular lymphoma is associated with favorable outcome in patients treated with R-CHOPMeredith M Nichols, Sarah L Ondrejka, Sujata Patil, et al.
Breast Cancer Research and Treatment|January 20, 2023
Pregnancy-associated breast cancer: does timing of presentation affect outcome?Angelena Crown, Damian McCartan, Michael A Curry, et al.
Cancer Medicine|June 20, 2014
The effect of metformin on breast cancer outcomes in patients with type 2 diabetesBridget A Oppong, Lindsay A Pharmer, Sabine Oskar, et al.
Cancer Medicine|March 27, 2023
Incidence and prognostic impact of HER2-positivity loss after dual HER2-directed neoadjuvant therapy for HER2+ breast cancerAlexis LeVee, Kellie Spector, Brigid Larkin, et al.
Clinical Breast Cancer|September 14, 2016
Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast CancerKaren A Cadoo, Patrick G Morris, Elizabeth P Cowell, et al.
Annals of Surgical Oncology|August 23, 2017
Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core BiopsyShirin Muhsen, Andrea V Barrio, Megan Miller, et al.
Pageof 23

Showing results (41-50 of 230) with videos related to

Sort By:
Pageof 23
Annals of Surgical Oncology|March 23, 2018
Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy RadiotherapyShirin Muhsen, Tracy-Ann Moo, Sujata Patil, et al.
Annals of Surgical Oncology|February 4, 2014
Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodesTracy-Ann Moo, Robert McMillan, Michele Lee, et al.
Annals of Surgical Oncology|November 20, 2012
Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?Daniel X Choi, Anne A Eaton, Cristina Olcese, et al.
Annals of Surgical Oncology|August 27, 2013
Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodesTracy Ann Moo, Robert McMillan, Michele Lee, et al.
Leukemia & Lymphoma|May 25, 2023
Ki67 proliferation index in follicular lymphoma is associated with favorable outcome in patients treated with R-CHOPMeredith M Nichols, Sarah L Ondrejka, Sujata Patil, et al.
Breast Cancer Research and Treatment|January 20, 2023
Pregnancy-associated breast cancer: does timing of presentation affect outcome?Angelena Crown, Damian McCartan, Michael A Curry, et al.
Cancer Medicine|June 20, 2014
The effect of metformin on breast cancer outcomes in patients with type 2 diabetesBridget A Oppong, Lindsay A Pharmer, Sabine Oskar, et al.
Cancer Medicine|March 27, 2023
Incidence and prognostic impact of HER2-positivity loss after dual HER2-directed neoadjuvant therapy for HER2+ breast cancerAlexis LeVee, Kellie Spector, Brigid Larkin, et al.
Clinical Breast Cancer|September 14, 2016
Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast CancerKaren A Cadoo, Patrick G Morris, Elizabeth P Cowell, et al.
Annals of Surgical Oncology|August 23, 2017
Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core BiopsyShirin Muhsen, Andrea V Barrio, Megan Miller, et al.
Pageof 23